Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.21.9185

MiR-1297 Regulates the Growth, Migration and Invasion of Colorectal Cancer Cells by Targeting Cyclo-oxygenase-2  

Chen, Pu (Department of Laboratory Medicine, Zhongshan Hospital, Fudan University)
Wang, Bei-Li (Department of Laboratory Medicine, Zhongshan Hospital, Fudan University)
Pan, Bai-Shen (Department of Laboratory Medicine, Zhongshan Hospital, Fudan University)
Guo, Wei (Department of Laboratory Medicine, Zhongshan Hospital, Fudan University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.21, 2014 , pp. 9185-9190 More about this Journal
Abstract
Cyclo-oxygenase-2(Cox-2), a key regulator of inflammation-producing prostaglandins, promotes cell proliferation and growth. Therefore, a better understanding of the regulatory mechanisms of Cox-2 could lead to novel targeted cancer therapies. MicroRNAs are strongly implicated in colorectal cancer but their specific roles and functions have yet to be fully elucidated. MiR-1297 plays an important role in lung adenocarcinoma and laryngeal squamous cell carcinoma, but its significance in colorectal cancer (CRC) has yet to be reported. In our present study, we found miR-1297 to be down regulated in both CRC-derived cell lines and clinical CRC samples, when compared with normal tissues. Furthermore, miR-1297 could inhibit human colorectal cancer LOVO and HCT116 cell proliferation, migration, and invasion in vitro and tumorigenesis in vivo by targeting Cox-2. Moreover, miR-1297 directly binds to the 3'-UTR of Cox-2, and the expression level was drastically decreased in LOVO and HCT116 cells following overexpression of miR-1297. Additionally, Cox-2 expression levels are inversely correlated with miR-1297 expression in human colorectal cancer xenograft tissues. These results imply that miR-1297 has the potential to provide a new approach to colorectal cancer therapy by directly inhibiting Cox-2 expression.
Keywords
Cox-2; miR; miR1297; colorectal cancer; HCT116 cells; LOVO cells;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Bonfrate L, Altomare DF, Di Lena M, et al (2013). MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment. J Gastrointestin Liver Dis, 22, 311-20.
2 Burn J, Mathers J and Bishop DT (2013). Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC). Recent Results Cancer Res, 191, 157-83.   DOI
3 Chan E, Lafleur B, Rothenberg ML, et al (2011). Dual blockade of the EGFR and COX-2 pathways: a phase II trial of cetuximab and celecoxib in patients with chemotherapy refractory metastatic colorectal cancer. Am J Clin Oncol, 34, 581-6.   DOI
4 Chulada PC, Thompson MB, Mahler JF, et al (2000). Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res, 60, 4705-8.
5 Committee ACPRW, Sawyers CL, Abate-Shen C, et al (2013). AACR Cancer Progress Report 2013. Clin Cancer Res, 19, 4-98.
6 Dang YW, Zeng J, He RQ, et al (2014). Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells. Asian Pac J Cancer Prev, 15, 4969-76.   과학기술학회마을   DOI
7 Eberhart CE, Coffey RJ, Radhika A, et al (1994). Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-8.
8 Esquela-Kerscher A and Slack FJ (2006). Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer, 6, 259-69.   DOI   ScienceOn
9 Hu F, Li D, Wang Y, et al (2013). Novel DNA variants and mutation frequencies of hMLH1 and hMSH2 genes in colorectal cancer in the Northeast China population. PLoS One, 8, 60233.   DOI
10 Kim VN, Han J and Siomi MC (2009). Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol, 10, 126-39.
11 Kong YW, Ferland-McCollough D, Jackson TJ, et al (2012). microRNAs in cancer management. Lancet Oncol, 13, 249-58.   DOI   ScienceOn
12 Li HY, Zhang Y, Cai JH, et al (2013). MicroRNA-451 inhibits growth of human colorectal carcinoma cells via downregulation of Pi3k/Akt pathway. Asian Pac J Cancer Prev, 14, 3631-4.   과학기술학회마을   DOI
13 Li X, Wang HL, Peng X, et al (2012). miR-1297 mediates PTEN expression and contributes to cell progression in LSCC. Biochem Biophys Res Commun, 427, 254-60.   DOI
14 Lin EH, Curley SA, Crane CC, et al (2006). Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival? Am J Clin Oncol, 29, 232-9.   DOI
15 Pereira C, Queiros S, Galaghar A, et al (2014). Genetic variability in key genes in prostaglandin E2 pathway (COX-2, HPGD, ABCC4 and SLCO2A1) and their involvement in colorectal cancer development. PLoS One, 9, 92000.   DOI
16 Malumbres M (2012). miRNAs versus oncogenes: the power of social networking. Mol Syst Biol, 8, 569.
17 Orang AV, Safaralizadeh R, Hosseinpour Feizi MA, et al (2014). Diagnostic and prognostic value of miR-205 in colorectal cancer. Asian Pac J Cancer Prev, 15, 4033-7.   과학기술학회마을   DOI
18 Oshima M, Dinchuk JE, Kargman SL, et al (1996). Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-9.   DOI   ScienceOn
19 Sano H, Kawahito Y, Wilder RL, et al (1995). Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res, 55, 3785-9.
20 Theodoratou E, Montazeri Z, Hawken S, et al (2012). Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer. J Natl Cancer Inst, 104, 1433-57.   DOI
21 Wang D and Dubois RN (2010). The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene, 29, 781-8.   DOI   ScienceOn
22 Wang D, Mann JR and DuBois RN (2005). The role of prostaglandins and other eicosanoids in the gastrointestinal tract. Gastroenterology, 128, 1445-61.   DOI   ScienceOn
23 Wang WH, Chen J, Zhao F, et al (2014). MiR-150-5p suppresses colorectal cancer cell migration and invasion through targeting MUC4. Asian Pac J Cancer Prev, 15, 6269-73.   과학기술학회마을   DOI
24 Yin J, Bai Z, Song J, et al (2014). Differential expression of serum miR-126, miR-141 and miR-21 as novel biomarkers for early detection of liver metastasis in colorectal cancer. Chin J Cancer Res, 26, 95-103.
25 Williams CS, Mann M and DuBois RN (1999). The role of cyclooxygenases in inflammation, cancer, and development. Oncogene, 18, 7908-16.
26 Xie SQ, Zhang YH, Li Q, et al (2012). COX-2-independent induction of apoptosis by celecoxib and polyamine naphthalimide conjugate mediated by polyamine depression in colorectal cancer cell lines. Int J Colorectal Dis, 27, 861-8.   DOI
27 Yi T, Yi Z, Cho SG, et al (2008). Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. Cancer Res, 68, 1843-50.   DOI
28 Zhang C, Chi YL, Wang PY, et al (2012). miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2. PLoS One, 7, 46090.   DOI
29 Zhang Y, Zheng L, Huang J, et al (2014). MiR-124 Radiosensitizes Human Colorectal Cancer Cells by Targeting PRRX1. PLoS One, 9, 93917.   DOI
30 Zhao H, Xu Z, Qin H, et al (2014). miR-30b regulates migration and invasion of human colorectal cancer via SIX1. Biochem J, 460, 117-25.   DOI